|
COX4NB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.796200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.268840E-01 |
| Normal-vs-Stage2 |
7.864100E-02 |
| Normal-vs-Stage3 |
1.322090E-02 |
| Normal-vs-Stage4 |
3.89889999999893E-05 |
| Stage1-vs-Stage2 |
2.563600E-03 |
| Stage1-vs-Stage3 |
1.376200E-01 |
| Stage1-vs-Stage4 |
8.161800E-04 |
| Stage2-vs-Stage3 |
3.219900E-04 |
| Stage2-vs-Stage4 |
1.3647000000061E-06 |
| Stage3-vs-Stage4 |
4.142400E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.195900E-03 |
| Normal-vs-AfricanAmerican |
2.404600E-01 |
| Normal-vs-Asian |
6.550200E-01 |
| Caucasian-vs-AfricanAmerican |
7.013400E-01 |
| Caucasian-vs-Asian |
1.095800E-01 |
| AfricanAmerican-vs-Asian |
4.817200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.940200E-02 |
| Normal-vs-Female |
7.596400E-02 |
| Male-vs-Female |
4.978800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.890500E-02 |
| Normal-vs-Age(41-60Yrs) |
7.822200E-02 |
| Normal-vs-Age(61-80Yrs) |
1.264570E-01 |
| Normal-vs-Age(81-100Yrs) |
6.048400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.645200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.149200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.120000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.410600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.023400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.110200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.191610E-04 |
| Classical-VS-Follicular |
2.419600E-03 |
| Classical-VS-Other |
5.006000E-01 |
| Classical-VS-Normal |
4.519700E-02 |
| Tall-VS-Follicular |
6.43359999719095E-08 |
| Tall-VS-Other |
6.034400E-01 |
| Tall-VS-Normal |
1.08259999997973E-06 |
| Follicular-VS-Other |
1.284960E-01 |
| Follicular-VS-Normal |
4.522600E-01 |
| Other-VS-Normal |
1.044800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.579000E-01 |
| Normal-vs-N1 |
1.569430E-04 |
| N0-vs-N1 |
6.03399999999921E-05 |
|
|
